In addition, western blot analysis in SMAP-treated tumors detected the simultaneous decrease in Akt/GSK3β/CyclinD1 signaling and ERK phosphorylation levels, suggesting that SMAP induces PP2A-dependent inhibition of these signaling pathways resulting in suppression of tumor growth (S8D Fig). The gene discussed is CCND1; the disease is neoplasm.